価格表

在庫・価格 : 2025年09月07日 08時46分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-TLR5, Mouse-Mono(19D759.2)
データシート
NBP2-24787 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 mg ¥96,000
(未発注)
追加

在庫・価格 : 2025年09月07日 08時46分 現在

Anti-TLR5, Mouse-Mono(19D759.2)

  • 商品コード:NBP2-24787
  • メーカー:NOV
  • 包装:0.1mg
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Kylm辰 AK et al. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma. Exp Mol Pathol 2020 06;114:104435
Kylm辰 AK et al
2020/01/01
PubMed
2 Na BH et al. Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-<i>&#x3BA;</i>B Activation in Human Myeloid Leukemia THP-1 Cells. Biomed Res Int 2018;2018:4319369
Na BH et al
2018/01/01
PubMed
3 Shang L et al. Differential influence of Streptococcus mitis on host response to metals in reconstructed human skin and oral mucosa. Contact Dermatitis 2020 Nov;83(5):347-360
Shang L et al
2020/01/01
PubMed
4 Kasurinen A et al. Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome. Sci Rep 2019 08;9(1):12553
Kasurinen A et al
2019/01/01
PubMed
5 Ruuskanen M et al. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma. BMC Cancer 2019 Jun;19(1):624
Ruuskanen M et al
2019/01/01
PubMed
6 Kairaluoma V et al. Toll-like receptor 5 and 8 in hepatocellular carcinoma. APMIS 2021 Aug;129(8):470-479
Kairaluoma V et al
2021/01/01
PubMed
7 Beilmann-Lehtonen I et al. High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients. Oncology 2021;99(9):589-600
Beilmann-Lehtonen I et al
2021/01/01
PubMed
8 Kitaura A et al. Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages. PLoS One 2021;16(1):e0245957
Kitaura A et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Kylm辰 AK et al. Elevated TLR5 expression in vivo and loss of NF-&#x3BA;&#x392; activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma. Exp Mol Pathol 2020 06;114:104435
    Kylm辰 AK et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Na BH et al. Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-<i>&#x3BA;</i>B Activation in Human Myeloid Leukemia THP-1 Cells. Biomed Res Int 2018;2018:4319369
    Na BH et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Shang L et al. Differential influence of Streptococcus mitis on host response to metals in reconstructed human skin and oral mucosa. Contact Dermatitis 2020 Nov;83(5):347-360
    Shang L et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kasurinen A et al. Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome. Sci Rep 2019 08;9(1):12553
    Kasurinen A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Ruuskanen M et al. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma. BMC Cancer 2019 Jun;19(1):624
    Ruuskanen M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Kairaluoma V et al. Toll-like receptor 5 and 8 in hepatocellular carcinoma. APMIS 2021 Aug;129(8):470-479
    Kairaluoma V et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Beilmann-Lehtonen I et al. High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients. Oncology 2021;99(9):589-600
    Beilmann-Lehtonen I et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Kitaura A et al. Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages. PLoS One 2021;16(1):e0245957
    Kitaura A et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed